Skip to content
Search

Latest Stories

Asda and Pharmacy2U join forces to revolutionize prescription access with online platform

Asda and Pharmacy2U join forces to revolutionize prescription access with online platform
As part of the Asda Online Pharmacy, patients to use click-and-collect option from any of the 232 pharmacy locations across the UK in the near future

In a recent announcement, the British supermarket chain, Asda has launched its first online prescription service becoming the first self-serving shop to offer prescribed medicine supply at the doorsteps through its latest healthcare accessibility venture.

The NHS certified online pharmacy service, Asda Online Pharmacy, is set to offer patients a digital platform designed to simplify the prescription process for patients, offering the convenience of online management and home delivery with their partnership with Pharmacy2U.


Effective immediately, new patients can register for an account on the platform via pharmacy.asda.com.

Once registered, they gain access to a seamless prescription ordering system that facilitates home delivery, along with the ability to monitor the progress of their orders.

Prescriptions submitted through Asda Online Pharmacy will undergo rigorous scrutiny by qualified pharmacists before being dispatched directly to patients' doorsteps, all without any additional charges.

Furthermore, Asda plans to introduce a click-and-collect option, allowing customers to pick up their prescriptions from any of the retailer's 232 pharmacy locations in the near future.

Faisal Tuddy, Head of Pharmacy and Superintendent Pharmacist at Asda Pharmacy, expressed enthusiasm for the initiative, stating, “We're thrilled to announce the launch of our online prescription delivery service with Pharmacy2U."

"By launching this platform, we are now able to reach even more Asda customers across the country, some of whom may not have an Asda Pharmacy nearby," he added.

He  further emphasized the importance of providing families with easy access to their repeat prescriptions, alleviating concerns about obtaining necessary medications.

This expansion, according to Tuddy, ensures greater convenience for patients, who can now effortlessly avail themselves of these services online.

Kevin Heath, CEO of Pharmacy2U, echoed Tuddy's sentiments, emphasizing their commitment to making healthcare accessible for all.

He expressed pride in partnering with Asda to bring their online prescription services to the retailer's customers, recognizing the pivotal role that supermarkets play in daily life.

"At Pharmacy2U, we’re committed to making healthcare easily accessible for the whole family. We are incredibly proud to have partnered with Asda to now bring our online prescription services to a place of ease for their customers."

Heath described the collaboration as "a natural yet exciting" progression for patients, underscoring the significance of merging convenience with essential healthcare services.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less